Natalizumab

• Description:

  Natalizumab used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  ——

• Molecular Formula:

  ——

• Notes:

  Research use only, not for human use.

• Receptor:

  Α4β1 integrin

• CAS Number:

  189261-10-7